查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1928630

经经皮机械血栓切除系统市场按类型、入路、应用和最终用途划分，全球预测（2026-2032）

Percutaneous Mechanical Thrombectomy System Market by Type, Access, Application, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，经皮机械血栓切除系统市场价值将达到 20 亿美元，到 2026 年将成长至 21.7 亿美元，到 2032 年将达到 34.5 亿美元，复合年增长率为 8.06%。

关键市场统计数据
基准年 2025 20亿美元
预计年份：2026年 21.7亿美元
预测年份 2032 34.5亿美元
复合年增长率 (%) 8.06%

本书着眼于未来，介绍了正在改变经皮血栓切除术实践的不断发展的技术、临床整合和跨学科动态。

经皮机械血栓切除术已成为治疗方法急性和慢性血栓性疾病的重要手段，它以微创方式快速清除血栓，从而重塑了临床实践。此领域充分利用导管工程、抽吸和旋转机制、雷射和超音波辅助装置以及影像导引导航等方面的进步，在提高手术成功率的同时，最大限度地减少血管损伤。随着手术团队将速度和安全性放在首位，器械设计也在不断发展，力求在血栓捕获、管腔保留和通过迂曲血管解剖结构的输送能力之间取得平衡，使得血栓切除术能够应用于广泛的血管区域。

临床需求、器械融合和基于价值的采购如何重塑经皮血栓切除术的策略和应用

随着器材创新、临床证据和医疗服务期望的融合，经经皮机械血栓切除术的格局正在改变性变化。一个显着的变化是适应症从传统的脑血管和冠状动脉疾病扩展到週边血管和复杂静脉疾病，在这些疾病中，器械的适应性和入路策略至关重要。同时，手术效率已成为关键的差异化因素，能够缩短准备时间、促进快速血栓捕获并与现有影像平台整合的系统在紧急情况下越来越受到重视。

评估近期和预期关税调整如何影响血栓除去装置生态系统的供应链韧性、筹资策略和购买行为。

源自美国的关税政策变化对经皮机械血栓切除系统的全球供应链、采购决策和设备成本结构产生了连锁反应。零件或成品进口关税的提高迫使製造商面临抉择：要么自行承担更高的投入成本，要么将其转嫁给买家，要么重组供应链以降低风险。每种选择都会影响采购週期、与医院的价格谈判以及现有供应商和新进业者之间的竞争格局。为此，许多製造商正在增加近岸外包，并实现供应商多元化，以减少对单一国家的依赖，并稳定生产计划。

透过详细的細項分析进行战术性定位，将设备需求与应用领域、技术等级、临床环境和准入策略连结起来。

深入了解产品和临床策略需要理解器械在应用、系统类型、最终使用环境和血管通路技术方面的定位。根据应用的不同，治疗路径涵盖了多种类型，包括针对颈动脉狭窄的颈动脉介入治疗、针对非ST段抬高型心肌梗塞（Non-STEMI）和ST段抬高型心肌梗塞（STEMI）的冠状动脉介入治疗、专门针对缺血性卒中的神经血管治疗，以及针对深层静脉栓塞症和周边动脉疾病的外周介入治疗。如此多样化的应用催生了不同的器械规格、手术流程和培训需求。例如，脑循环介入治疗优先考虑微导管的操控性，而周边介入治疗则强调其在大血管血栓切除术中的稳健性。

区域卫生系统、报销环境和基础设施成熟度如何导致全球主要区域采用路径的差异

区域趋势在经皮机械血栓切除技术的研发、应用和报销中起着至关重要的作用。在美洲，完善的临床网路和高度普及的先进介入治疗基础设施支援创新系统的快速应用。然而，报销机制和医院采购週期会影响技术的采用时间和规模。相较之下，欧洲、中东和非洲地区（EMEA）的医疗保健模式多种多样，集中采购和国家指南在某些市场加速了技术的普及，而在其他市场则延长了普及进程。监管协调和跨境临床合作是该地区的关键驱动因素。

塑造血栓清除领域竞争格局的策略性企业行动：定向创新、临床支援计画和伙伴关係的主导组合拓展

透过各公司活动的检验，可以发现构成血栓切除系统竞争格局的几个策略主题。领先的医疗设备製造商和专业创新企业正在采取差异化策略，将产品改进、扩展的临床证据和服务相结合，以深化与医院的合作关係。一些公司专注于改进导管几何形状和抽吸效率，以缩短手术时间并提高首次手术成功率；而另一些公司则投资于混合系统，将机械作用与基于能量的血栓修饰相结合，以应对更复杂的阻塞情况。对临床医生培训计画和模拟教育的策略性投资对于支持技术应用、缩短学习曲线以及促进医疗机构的广泛采用至关重要。

为製造商和医疗系统提供可操作的策略重点，以加速产品推广应用、控製成本压力并使产品开发与临床需求保持一致。

为了使技术进步与临床需求和采购实践相契合，产业领导者应围绕以下可操作的优先事项制定策略。首先，透过投资多学科临床证据，证明设备在关键适应症（例如颈动脉狭窄、急性冠状动脉症候群、缺血性中风、深层静脉栓塞症和周边动脉疾病）中的性能，从而赢得不同手术团队的信任。其次，优先考虑产品的模组化和互通性，透过与现有成像和支援平台无缝集成，降低采用门槛。第三，积极拓展供应来源，并考虑本地化生产和组装，以降低关税风险并缩短前置作业时间。

本研究的调查方法明确说明为混合方法，结合了临床医生访谈、技术设备分析和临床文献综合，以确保得出可靠的结论。

本分析所依据的研究整合了对关键相关人员的访谈、设备层面的技术审查、同行评审的临床研究以及对专业学会指南的严格评估。主要资料来源包括对介入医师、医院采购人员和设备技术人员的结构化访谈，以了解实际操作中的限制、采购考虑和性能预期。这些观点与临床文献的系统性回顾相结合，以评估相对安全性、首次手术成功率以及对血管外科各学科手术流程的影响。

总之，这项综合性综述强调了关键因素（设备性能、临床证据和供应弹性）的汇聚，这些因素共同塑造了未来血栓切除术的普及。

经经皮机械血栓切除术正处于策略转折点，器械创新、临床证据和医疗保健系统优先事项在此交汇，共同决定未来的治疗路径。无论适应症如何，重点在于实现更安全、更快速、更可重复的手术，成功的解决方案将结合高效能的器械、精简的工作流程和强大的临床支援。稳健的供应链、监管合作和本地化的商业化计划对于确保在各种医疗机构中持续可及和广泛应用至关重要。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 经经皮机械血栓切除系统市场（按类型划分）

  • 吸力系统
  • 雷射系统
  • 旋转系统
  • 超音波系统

第九章 经经皮机械血栓切除系统市场（以入路方式划分）

  • 肱动脉路
  • 股动脉路径
  • 桡动脉入路

第十章经皮机械血栓切除系统市场（依应用划分）

  • 颈动脉
  • 冠状动脉
    • 非ST段抬高型心肌梗塞
    • ST段上升型心肌梗塞
  • 神经血管
  • 外围
    • 深层静脉栓塞症
    • 周边动脉疾病

第十一章 经经皮机械血栓切除系统市场（依最终用途划分）

  • 门诊手术中心
  • 诊所
  • 医院

第十二章经皮机械血栓切除系统市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章经皮机械血栓切除系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国经经皮机械血栓切除系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国经皮机械血栓切除系统市场

16. 中国经皮机械血栓切除系统市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • AngioDynamics, Inc.
  • Balt Extrusion SAS
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Edwards Lifesciences Corporation
  • Inari Medical, Inc.
  • Johnson & Johnson
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Penumbra, Inc.
  • phenox GmbH
  • Rapid Medical, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vesalio, LLC
Product Code: MRR-92740D85F07B

The Percutaneous Mechanical Thrombectomy System Market was valued at USD 2.00 billion in 2025 and is projected to grow to USD 2.17 billion in 2026, with a CAGR of 8.06%, reaching USD 3.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.00 billion
Estimated Year [2026] USD 2.17 billion
Forecast Year [2032] USD 3.45 billion
CAGR (%) 8.06%

A forward-looking introduction to the evolving technology, clinical integration, and interdisciplinary dynamics transforming percutaneous thrombectomy practice

Percutaneous mechanical thrombectomy has emerged as a critical intervention across acute and chronic thrombotic conditions, reshaping clinical practice by enabling rapid clot removal with minimally invasive approaches. The field draws on advances in catheter engineering, aspiration and rotational mechanics, laser and ultrasonic adjuncts, and imaging-guided navigation to improve procedural success while minimising vessel trauma. As procedural teams prioritize speed and safety, device designs have evolved to balance clot engagement, lumen preservation, and deliverability through tortuous anatomy, making thrombectomy techniques applicable across a broad spectrum of vascular territories.

Contemporary practice demands integrated solutions that harmonize device performance with workflow efficiency, from pre-procedural imaging to post-procedural recovery. This imperative has driven cross-disciplinary collaboration among interventional cardiology, neurointerventional, vascular surgery, and interventional radiology communities. Consequently, evidence generation has focused on patient selection criteria, comparative safety profiles, and real-world procedural metrics, informing clinical guidelines and hospital adoption. Looking forward, ongoing refinements in materials science, catheter profiles, and adjunctive pharmacology are expected to enhance the therapeutic index of percutaneous mechanical thrombectomy and to expand its role within both acute stroke pathways and peripheral vascular interventions.

How intersecting clinical demands, device convergence, and value-based procurement are reshaping percutaneous thrombectomy strategies and adoption

The landscape for percutaneous mechanical thrombectomy is undergoing transformative shifts as device innovation, clinical evidence, and care-delivery expectations converge. One prominent change is the broadening of indications beyond traditional cerebrovascular and coronary settings into peripheral and complex venous territories, where device adaptability and access strategies matter greatly. At the same time, procedural efficiency has become a primary differentiator; systems that reduce setup time, facilitate rapid clot engagement, and integrate with existing imaging platforms are increasingly favored in high-acuity environments.

Technological convergence is also notable. Hybrid designs that combine aspiration with mechanical fragmentation, or integrate ultrasonic energy to augment clot disruption, are redefining performance benchmarks. Alongside device evolution, payer and provider emphasis on value-based care is reshaping procurement decisions, prompting manufacturers to demonstrate not only clinical effectiveness but also downstream impact on length of stay, readmissions, and rehabilitation needs. Finally, the rise of modular ecosystems-where catheters, guidewires, and support platforms are designed for seamless compatibility-reflects a system-level shift toward interoperability, repeatable procedural workflows, and clinician-centric user experiences.

Assessing how recent and prospective tariff adjustments are influencing supply chain resilience, sourcing strategies, and procurement behavior in thrombectomy device ecosystems

Tariff policy changes originating from the United States have a cascading influence on global supply chains, sourcing decisions, and device cost structures for percutaneous mechanical thrombectomy systems. When import duties increase on components or finished devices, manufacturers confront immediate choices: absorb higher input costs, pass them through to purchasers, or restructure supply chains to mitigate exposure. Each option carries implications for procurement cycles, pricing negotiations with hospitals, and the competitive landscape among established vendors and new entrants. In response, many manufacturers pursue nearshoring or diversify supplier bases to limit single-country dependencies and to stabilize production timelines.

Beyond direct input costs, tariff adjustments can affect the cadence of clinical trials and international regulatory filings when key components or system modules originate from affected regions. Delays in component availability may slow product iterations and limit the rollout of software-enabled upgrades that rely on integrated hardware. Healthcare providers can experience indirect impacts as procurement teams recalibrate capital equipment budgets, prioritizing devices with locally sourced components or longer service lifecycles. In combination, these dynamics encourage collaboration between manufacturers and hospital systems to structure long-term supply agreements, hedge against tariff volatility through contractual clauses, and invest in supply chain transparency. Such measures preserve access to critical thrombectomy devices while offering predictability for clinical programs and capital planning.

Deep-dive segmentation insights linking application-specific device requirements, technology classes, clinical environments, and access strategies for tactical positioning

Insight into product and clinical strategy requires an understanding of how devices are positioned across applications, system types, end-use environments, and vascular access approaches. Based on application, therapeutic pathways span carotid artery interventions focused on carotid stenosis, coronary procedures addressing both Non-STEMI and STEMI presentations, neurovascular treatment specifically oriented to ischemic stroke, and peripheral interventions for deep vein thrombosis and peripheral arterial disease. This range of applications drives distinct device specifications, procedural workflows, and training demands, as cerebral circulation procedures prioritize microcatheter maneuverability while peripheral interventions emphasize robustness for large-vessel thrombus extraction.

Based on type, the technology landscape includes aspiration systems, laser systems, rotational systems, and ultrasonic systems, each offering different mechanisms for clot engagement and fragmentation. Device selection is influenced by thrombus composition, anatomical constraints, and procedural objectives, with aspiration systems often favored for soft thrombus and rotational or laser solutions considered for more organized occlusions. Based on end use, the mix of ambulatory surgical centers, clinics, and hospitals shapes procurement criteria; hospitals handle the highest-acuity cases and require integrated imaging and hybrid operating environments, whereas ambulatory and clinic settings prioritize rapid turnover and standardized procedural kits. Based on access, clinicians rely on brachial access, femoral access, and radial access depending on anatomical reach, complication profiles, and operator preference, and access strategy informs training, ancillary equipment needs, and post-procedural monitoring protocols.

How regional healthcare systems, reimbursement landscapes, and infrastructure maturity create distinct adoption pathways across major global territories

Regional dynamics play a pivotal role in how percutaneous mechanical thrombectomy technologies are developed, adopted, and reimbursed. In the Americas, established clinical networks and a high prevalence of advanced interventional infrastructure favor rapid adoption of innovative systems, while reimbursement frameworks and hospital procurement cycles influence the timing and scale of deployments. In contrast, Europe, Middle East & Africa encompasses diverse healthcare models where centralized procurement and national-level guideline development can accelerate uptake in some markets while creating longer adoption curves in others; regulatory harmonization and cross-border clinical collaborations are important enablers in this region.

Asia-Pacific presents a mix of rapidly modernizing healthcare systems, large patient populations, and an expanding base of locally manufactured technologies that can compete on cost and bespoke design. Across all regions, differences in procedural volumes, clinician training pathways, and infrastructure maturity shape device preferences and support models. While global clinical evidence informs practice universally, regional reimbursement policies, referral patterns, and hospital capital planning introduce local variance in adoption trajectories and in the competitive strategies manufacturers pursue to gain traction.

Strategic corporate behaviors shaping the thrombectomy competitive field through targeted innovation, clinical support programs, and partnership-driven portfolio expansion

A review of company activity highlights several strategic themes defining the competitive environment for thrombectomy systems. Leading medical device firms and specialist innovators are pursuing differentiated approaches that combine product refinement, expanded clinical evidence, and service offerings to deepen hospital relationships. Some companies concentrate on refining catheter geometry and aspiration efficiency to reduce procedure time and increase first-pass success rates, while others invest in hybrid systems that pair mechanical action with energy-based clot modification to address tougher occlusions. Strategic investments in clinician training programs and simulation-based education have become essential to support adoption, reducing learning curves and enabling broader use across institutional settings.

Mergers, acquisitions, and partnership models remain common as device manufacturers seek to augment portfolios with complementary technologies, software-enabled imaging integrations, and market access capabilities. Aftermarket services such as field-based technical support, warranty structures, and consumable management are increasingly central to commercial discussions, given hospitals' focus on predictable total cost of ownership. Finally, companies that provide clear evidence of device safety across multiple vascular territories and that demonstrate compatibility with common access strategies often secure stronger clinical endorsements, facilitating inclusion in care protocols and procurement frameworks.

Practical strategic priorities for manufacturers and health systems to accelerate adoption, manage cost pressures, and align product development with clinical demand

Industry leaders should orient strategy around several actionable priorities that align technological progress with clinical needs and procurement realities. First, invest in cross-disciplinary clinical evidence that demonstrates device performance across the key application areas-carotid stenosis, coronary acute coronary syndromes, ischemic stroke, deep vein thrombosis, and peripheral arterial disease-to build credibility with diverse procedural teams. Second, prioritise product modularity and interoperability so devices integrate smoothly with prevailing imaging platforms and support platforms, thereby reducing adoption friction. Third, proactively diversify supply sources and consider localized manufacturing or assembly to mitigate tariff exposure and to shorten lead times for customers.

Equally important is the enhancement of clinician training and procedural simulation offerings to accelerate skill uptake and to reduce variability in outcomes. Commercially, adopting flexible pricing constructs, outcome-linked contracting, and bundled purchasing options can align vendor incentives with hospital priorities and support procurement approvals. Finally, engage with regulatory bodies and payer stakeholders early to clarify real-world evidence requirements and reimbursement pathways, ensuring that commercialization timelines reflect both clinical validation and reimbursement readiness.

Transparent description of the mixed-methods research approach combining clinician interviews, technical device analysis, and clinical literature synthesis to ensure robust conclusions

The research underpinning this analysis synthesizes primary stakeholder interviews, device-level technical review, and a rigorous appraisal of peer-reviewed clinical studies and professional society guidance. Primary inputs included structured interviews with interventional clinicians, hospital procurement leaders, and device engineers to capture real-world procedural constraints, procurement considerations, and performance expectations. Those perspectives were integrated with a systematic review of clinical literature to assess comparative safety profiles, first-pass success narratives, and procedural workflow implications across vascular territories.

Complementing qualitative insights, a technical analysis of device architectures and mechanism-of-action classifications-aspiration, laser, rotational, and ultrasonic-provided a basis for evaluating suitability across thrombus types and access strategies. Supply chain and policy analyses examined component sourcing, tariff exposures, and manufacturing footprint considerations to surface resilience strategies. Throughout, findings were triangulated to ensure consistency between clinical imperatives, engineering constraints, and commercial realities, yielding conclusions that are directly actionable for device developers, hospital system leaders, and strategic investors.

Concluding synthesis emphasizing the critical convergence of device performance, clinical evidence, and supply resilience shaping future thrombectomy adoption

Percutaneous mechanical thrombectomy stands at a strategic inflection point where device innovation, clinical evidence, and health system priorities intersect to determine future pathways of care. Across anatomical indications, the emphasis is on achieving safer, faster, and more reproducible procedures, and successful solutions will be those that reconcile high-performance mechanics with streamlined workflows and robust clinician support. Supply chain resilience, regulatory engagement, and regionally informed commercialization plans will be essential to sustain access and to enable widespread adoption across varied healthcare settings.

Ultimately, stakeholders who align product development with clinician needs, invest in rigorous evidence generation, and structure commercial models that address hospital fiscal constraints will be best positioned to influence care protocols and to capture long-term clinical endorsement. By focusing on modular design, interoperability, and comprehensive training programs, manufacturers can lower barriers to adoption and contribute meaningfully to improved patient outcomes across neurovascular, coronary, carotid, and peripheral vascular domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Mechanical Thrombectomy System Market, by Type

  • 8.1. Aspiration Systems
  • 8.2. Laser Systems
  • 8.3. Rotational Systems
  • 8.4. Ultrasonic Systems

9. Percutaneous Mechanical Thrombectomy System Market, by Access

  • 9.1. Brachial Access
  • 9.2. Femoral Access
  • 9.3. Radial Access

10. Percutaneous Mechanical Thrombectomy System Market, by Application

  • 10.1. Carotid Artery
  • 10.2. Coronary
    • 10.2.1. Non Stemi
    • 10.2.2. Stemi
  • 10.3. Neurovascular
  • 10.4. Peripheral
    • 10.4.1. Deep Vein Thrombosis
    • 10.4.2. Peripheral Arterial Disease

11. Percutaneous Mechanical Thrombectomy System Market, by End Use

  • 11.1. Ambulatory Surgical Center
  • 11.2. Clinic
  • 11.3. Hospital

12. Percutaneous Mechanical Thrombectomy System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Percutaneous Mechanical Thrombectomy System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Percutaneous Mechanical Thrombectomy System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Percutaneous Mechanical Thrombectomy System Market

16. China Percutaneous Mechanical Thrombectomy System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Acandis GmbH & Co. KG
  • 17.7. AngioDynamics, Inc.
  • 17.8. Balt Extrusion S.A.S.
  • 17.9. Boston Scientific Corporation
  • 17.10. Cook Medical, Inc.
  • 17.11. Edwards Lifesciences Corporation
  • 17.12. Inari Medical, Inc.
  • 17.13. Johnson & Johnson
  • 17.14. LeMaitre Vascular, Inc.
  • 17.15. Medtronic plc
  • 17.16. Merit Medical Systems, Inc.
  • 17.17. MicroVention, Inc.
  • 17.18. Penumbra, Inc.
  • 17.19. phenox GmbH
  • 17.20. Rapid Medical, Inc.
  • 17.21. Stryker Corporation
  • 17.22. Teleflex Incorporated
  • 17.23. Terumo Corporation
  • 17.24. Vesalio, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ASPIRATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ASPIRATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ASPIRATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ROTATIONAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ROTATIONAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ROTATIONAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ULTRASONIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ULTRASONIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ULTRASONIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY BRACHIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY BRACHIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY BRACHIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CAROTID ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CAROTID ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CAROTID ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NON STEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NON STEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NON STEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY STEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY STEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY STEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 151. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 154. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 161. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)